← All trials
NCT05809830
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 29, 2023
- Primary completion
- Nov 8, 2023
- Completion date
- May 8, 2026
- First posted
- Apr 12, 2023
- Last posted
- Oct 23, 2023
- Enrollment
- 152
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Grupo Espanol de Investigacion en SarcomasLead sponsor
- Universidad Autonoma de MadridOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.